Cargando…
Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells
Corneal disease affects 12.5 million individuals worldwide, with 2 million new cases each year. The standard treatment consists of a corneal transplantation from a human donor; however, the worldwide demand significantly exceeds the available supply. Lamellar endothelial keratoplasty, the replacemen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585097/ https://www.ncbi.nlm.nih.gov/pubmed/34769411 http://dx.doi.org/10.3390/ijms222111982 |
_version_ | 1784597609240854528 |
---|---|
author | Marta, Cadenas-Martin Adrian, Moratilla Jorge, Fernández-Delgado Francisco, Arnalich-Montiel De Miguel, Maria P. |
author_facet | Marta, Cadenas-Martin Adrian, Moratilla Jorge, Fernández-Delgado Francisco, Arnalich-Montiel De Miguel, Maria P. |
author_sort | Marta, Cadenas-Martin |
collection | PubMed |
description | Corneal disease affects 12.5 million individuals worldwide, with 2 million new cases each year. The standard treatment consists of a corneal transplantation from a human donor; however, the worldwide demand significantly exceeds the available supply. Lamellar endothelial keratoplasty, the replacement of only the endothelial layer of the cornea, can partially solve the problem. Progressive efforts have succeeded in expanding hCECs; however, the ability to expand hCECs is still limited, and new sources of CECs are being sought. Crucial advances have been achieved by the directed differentiation of embryonic or induced pluripotent stem cells, but these cells have disadvantages, such as the use of oncogenes, and are still difficult to establish. We aimed to transfer such knowledge to obtain hCECs from adipose tissue-derived adult mesenchymal stem cells (ADSC) by modifying four previously published procedures. We present several protocols capable of the directed differentiation of human ADSCs to hCECs. In our hands, the protocol by Ali et al. was the best adapted to such differentiation in terms of efficiency, time, and financial cost; however, the protocol by Wagoner et al. was the best for CEC marker expression. Our results broaden the type of cells of autologous extraocular origin that could be employed in the clinical setting for corneal endothelial deficiency. |
format | Online Article Text |
id | pubmed-8585097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85850972021-11-12 Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells Marta, Cadenas-Martin Adrian, Moratilla Jorge, Fernández-Delgado Francisco, Arnalich-Montiel De Miguel, Maria P. Int J Mol Sci Article Corneal disease affects 12.5 million individuals worldwide, with 2 million new cases each year. The standard treatment consists of a corneal transplantation from a human donor; however, the worldwide demand significantly exceeds the available supply. Lamellar endothelial keratoplasty, the replacement of only the endothelial layer of the cornea, can partially solve the problem. Progressive efforts have succeeded in expanding hCECs; however, the ability to expand hCECs is still limited, and new sources of CECs are being sought. Crucial advances have been achieved by the directed differentiation of embryonic or induced pluripotent stem cells, but these cells have disadvantages, such as the use of oncogenes, and are still difficult to establish. We aimed to transfer such knowledge to obtain hCECs from adipose tissue-derived adult mesenchymal stem cells (ADSC) by modifying four previously published procedures. We present several protocols capable of the directed differentiation of human ADSCs to hCECs. In our hands, the protocol by Ali et al. was the best adapted to such differentiation in terms of efficiency, time, and financial cost; however, the protocol by Wagoner et al. was the best for CEC marker expression. Our results broaden the type of cells of autologous extraocular origin that could be employed in the clinical setting for corneal endothelial deficiency. MDPI 2021-11-05 /pmc/articles/PMC8585097/ /pubmed/34769411 http://dx.doi.org/10.3390/ijms222111982 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marta, Cadenas-Martin Adrian, Moratilla Jorge, Fernández-Delgado Francisco, Arnalich-Montiel De Miguel, Maria P. Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title | Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title_full | Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title_fullStr | Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title_full_unstemmed | Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title_short | Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells |
title_sort | improvement of an effective protocol for directed differentiation of human adipose tissue-derived adult mesenchymal stem cells to corneal endothelial cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585097/ https://www.ncbi.nlm.nih.gov/pubmed/34769411 http://dx.doi.org/10.3390/ijms222111982 |
work_keys_str_mv | AT martacadenasmartin improvementofaneffectiveprotocolfordirecteddifferentiationofhumanadiposetissuederivedadultmesenchymalstemcellstocornealendothelialcells AT adrianmoratilla improvementofaneffectiveprotocolfordirecteddifferentiationofhumanadiposetissuederivedadultmesenchymalstemcellstocornealendothelialcells AT jorgefernandezdelgado improvementofaneffectiveprotocolfordirecteddifferentiationofhumanadiposetissuederivedadultmesenchymalstemcellstocornealendothelialcells AT franciscoarnalichmontiel improvementofaneffectiveprotocolfordirecteddifferentiationofhumanadiposetissuederivedadultmesenchymalstemcellstocornealendothelialcells AT demiguelmariap improvementofaneffectiveprotocolfordirecteddifferentiationofhumanadiposetissuederivedadultmesenchymalstemcellstocornealendothelialcells |